Mesangial expansion, glomerular atrophy, and glomerular basement membrane thickening showed a trend to improvement in the sitagliptin-treated diabetic rats versus the untreated (Figures 3(b) , 3(c) , and 3(d) and Table 3 ).
← all excerpts
Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).
1
—
—